Inactive Instrument

MERCK Kommanditgesellschaft auf Aktien Stock Other OTC

Equities

MKKGY

US5893392093

Pharmaceuticals

Sales 2024 * 21.25B 22.73B Sales 2025 * 22.5B 24.07B Capitalization 66.24B 70.86B
Net income 2024 * 2.97B 3.18B Net income 2025 * 3.48B 3.72B EV / Sales 2024 * 3.44 x
Net Debt 2024 * 6.79B 7.26B Net Debt 2025 * 4.83B 5.17B EV / Sales 2025 * 3.16 x
P/E ratio 2024 *
22.3 x
P/E ratio 2025 *
19 x
Employees -
Yield 2024 *
1.52%
Yield 2025 *
1.59%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on MERCK Kommanditgesellschaft auf Aktien

Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Chairman 67 19-04-25
Director/Board Member 61 12-04-30
More insiders
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company